-
Founded in:
1996-06-06 -
Country:
China -
Address:
No. 2, Xingye East Road, Limin Economic and Technological Development Zone, Harbin -
Tax NO.:
912301111280389648 -
Registered Funds:
110 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetaminophen |
It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects
More
It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects |
250mg | 103-90-2 | 68 |
| Caffeine |
It is a central nervous system stimulant that can enhance the antipyretic and analgesic effects of acetaminophen and reduce central nervous system inhibitory effects such as drowsiness and dizziness caused by other drugs.
More
It is a central nervous system stimulant that can enhance the antipyretic and analgesic effects of acetaminophen and reduce central nervous system inhibitory effects such as drowsiness and dizziness caused by other drugs. |
15mg | 0 | |
| Chlorphenamine maleate |
It is an antihistamine that can relieve runny nose, nasal congestion, and sneezing symptoms.
More
It is an antihistamine that can relieve runny nose, nasal congestion, and sneezing symptoms. |
1mg | 113-92-8 | 28 |
| Atificial Cow-bezoar |
It has antipyretic and sedative effects
More
It has antipyretic and sedative effects |
10mg | 1002-00-2 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| REHMANNIAE RADIX PRAEPARATA |
|
0 | ||
| Anise oil |
|
8007-70-3 | 10 | |
| Ophiopogonis Radix |
|
0 | ||
| MOUTAN CORTEX |
|
0 | ||
| Astragali Radix |
|
0 | ||
| COPTIDISRHIZOMA |
|
0 | ||
| Poria |
|
0 | ||
| Red ginseng |
|
0 | ||
| Trichosanthes |
|
0 | ||
| Calcium sulfate dihydrate |
|
10101-41-4 | 0 | |
| lycii Fructus |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 1，1-DIMETHYLBIGUANIDE HYDROCHLORIDE |
This product is a hypoglycemic drug that can reduce fasting and postprandial hyperglycemia in patients with type 2 diabetes, and can reduce HbAlc by 1% to 2%. Its mechanism of lowering blood sugar is: 1. Increase the sensitivity of peripheral tissues to insulin and increase insulin-mediated glucose utilization. 2. Increase the utilization of glucose by non-insulin-dependent tissues, such as the brain, blood cells, renal medulla, intestines, skin, etc. 3. Inhibit hepatic gluconeogenesis and reduce hepatic glucose output. 4. Inhibit intestinal wall cells from taking up glucose. Unlike the action of insulin, this product has no effect on promoting fat synthesis, has no obvious hypoglycemic effect on normal people, and generally does not cause hypoglycemia when used alone for type 2 diabetes.
More
This product is a hypoglycemic drug that can reduce fasting and postprandial hyperglycemia in patients with type 2 diabetes, and can reduce HbAlc by 1% to 2%. Its mechanism of lowering blood sugar is: 1. Increase the sensitivity of peripheral tissues to insulin and increase insulin-mediated glucose utilization. 2. Increase the utilization of glucose by non-insulin-dependent tissues, such as the brain, blood cells, renal medulla, intestines, skin, etc. 3. Inhibit hepatic gluconeogenesis and reduce hepatic glucose output. 4. Inhibit intestinal wall cells from taking up glucose. Unlike the action of insulin, this product has no effect on promoting fat synthesis, has no obvious hypoglycemic effect on normal people, and generally does not cause hypoglycemia when used alone for type 2 diabetes. |
15537-72-1 | 55 |